Table: Rohto -Q1 group results

Rohto Pharmaceutical

08/08/2016 07:00

Aug 8 (Reuters)-  
             Rohto Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   3 months ended      3 months ended       Year to  
                  Jun 30, 2016        Jun 30, 2015     Mar 31, 2017  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               32.88               35.43           163.00     
                   (-7.2 pct)          (+18.0 pct)      (-2.4 pct)   
  Operating            2.22                1.86            15.50     
                   (+19.4 pct)        (+166.1 pct)      (-1.2 pct)   
  Recurring            2.43                2.15            15.20     
                   (+13.1 pct)         (+94.9 pct)      (-0.9 pct)   
  Net                  1.37                1.33             9.50     
                   (+3.4 pct)         (+104.7 pct)      (+4.4 pct)   
  EPS               12.07 yen           11.69 yen        83.47 yen   
  EPS Diluted       12.02 yen           11.64 yen                    
  Ann Div                               20.00 yen        21.00 yen   
  -Q2 div                               10.00 yen        10.00 yen   
  -Q4 div                               10.00 yen        11.00 yen   
   
  NOTE - Rohto Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T  
  ((Tokyo Headline News Desk +813 6441 1812))